TSOUKAS, M. A. Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Canadian Diabetes & Endocrinology Today, [S. l.], v. 1, n. 3, p. 21–26, 2023. DOI: 10.58931/cdet.2023.1318. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/1-3-tsoukas. Acesso em: 10 may. 2024.